Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INTERFERON GAMMA for Chronic granulomatous disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 29 adverse event reports in the FDA FAERS database where INTERFERON GAMMA was used for Chronic granulomatous disease.

Most Reported Side Effects for INTERFERON GAMMA

Side Effect Reports % Deaths Hosp.
Off label use 39 28.7% 11 22
Drug ineffective 33 24.3% 14 18
Pyrexia 12 8.8% 6 7
Bronchopulmonary aspergillosis 11 8.1% 9 11
Pneumonia 10 7.4% 4 5
Respiratory failure 10 7.4% 10 8
Agranulocytosis 9 6.6% 0 9
Malignant neoplasm progression 9 6.6% 0 0
Acute respiratory distress syndrome 8 5.9% 8 8
Cerebral haemorrhage 8 5.9% 8 8
Neutropenia 8 5.9% 0 8
Cerebral aspergillosis 7 5.2% 7 7
Condition aggravated 7 5.2% 5 4
Shock haemorrhagic 7 5.2% 7 7
Treatment failure 7 5.2% 2 3

Other Indications for INTERFERON GAMMA

Product used for unknown indication (14) Immunodeficiency (11) Malignant melanoma stage iv (10) Aspergillus infection (9) Immunomodulatory therapy (7) Mycobacterial infection (6)

Other Drugs Used for Chronic granulomatous disease

INTERFERON GAMMA-1B (539) BUSULFAN (68) FLUDARABINE (37) INFLIXIMAB (36) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (24) ADALIMUMAB (20) ALEMTUZUMAB (16) METHYLPREDNISOLONE (16) CYCLOPHOSPHAMIDE (15) THIOTEPA (15)

Related Pages

INTERFERON GAMMA Full Profile All Chronic granulomatous disease Drugs INTERFERON GAMMA Demographics INTERFERON GAMMA Timeline